Morning Report: US sharemarkets were closed on Monday
Over the week, the Dow fell by 0.2%, the S&P 500 rose by 0.6% and the Nasdaq gained 1.6%.
Read MoreOver the week, the Dow fell by 0.2%, the S&P 500 rose by 0.6% and the Nasdaq gained 1.6%.
Read MoreStruggling women’s fashionwear retailer Mosaic Brands has confirmed the details of its capital raising after a delay over the weekend in a move that ended up being cheered by investors.
Read MoreMichael Price, Portfolio Manager of Ausbil’s Active Dividend Income Fund, gives his thoughts on where investors need to look in the current market to keep their dividend income flowing in.
Read MoreInvestment group Washington H. Soul Pattinson upgraded its 2020-21 earnings guidance as it prepares to merge with another Sydney listed investor in Milton Investment Corp.
Read MoreSoon-to-split energy giant AGL is one of three notable companies to be dropped from the ASX 50 subindex of the ASX 200 in the quarterly recasting by S&P Dow Jones.
Read MoreAfter releasing a FY21 result with virtually all major numbers heading emphatically north, Perth-based real estate disruptor The Agency Limited is justifiably feeling buoyant about the future.
Read MoreShares in Hansen Technologies were sold off heavily in ASX trading on Monday following the departure of private equity group BGH Capital from the bidding lounge.
Read MoreThe Australian sharemarket is sliding on Monday, with losses across most sectors at midday. Fortescue Metals is the main weight as it trades ex-dividend for its largest ever distribution to investors next month.
Read MoreCatch up on the full webinar with presentations from Cynata Therapeutics (ASX: CYP), Atomo Diagnostics (ASX: AT1), NeuroScientific (ASX: NSB) & Kazia Therapeutics (ASX: KZA).
Read MoreASX200 down 74 points (1%) to 7449. Hansen Technologies (-11%); BGH Capital withdraws takeover proposal for Hansen.
Read MoreDr Ross Macdonald – Managing Director and Chief Executive Officer – Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology.
Read MoreJames Garner – Managing Director & CEO – Kazia Therapeutics Limited is an innovative oncology-focused biotechnology company. Kazia is working to develop therapies across a range of oncology indications.
Read MoreDougal Thring – VP Clinical Development – NeuroScientific Biopharmaceuticals is developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical needs.
Read MoreJohn Kelly – Founder, Managing Director & CEO – Atomo Diagnostics Limited is a global leader in the design of medical devices for blood-based rapid testing for professional use and self-testing.
Read MoreTech stocks rose but bank stocks fell. The Dow Jones index fell by 75 points or 0.2%.
Read MoreThe Labor Day holiday in the US tonight will leave markets wondering about direction for an extra 24 hours after Friday saw the release of the weakest jobs data so far this year.
Read MoreA plan for a new stock exchange in Beijing has raised eyebrows in Asian financial markets, coming as it did last Thursday without any notice. What, prey tell, is the government up to?
Read MoreFriday’s weak US jobs report saw renewed interest in gold, helped weaken the value of the US dollar and sparked delight among many investors that the free money looks set to continue for a while longer.
Read MoreA quiet week ahead starting with the US Labor Day holiday, with the Reserve Bank’s monetary policy decision tomorrow dominating local attention as well as August employment data on Thursday.
Read MoreWe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. So here it is in one handy location. You’re welcome.
Read MoreThings have turned a bit grim of late with Delta cases both locally and abroad showing no signs of slowing. But, as AMP Capital’s Shane Oliver argues in his regular column, things aren’t as bad as they might seem.
Read MoreShortages of workers and computer chips are having a dramatic impact on the US economy – keeping inflation higher while shutting factories and forcing retailers to boost wages.
Read MoreJune quarter data confirms not only that gold is where the mining and resources crowd is heading, but the production figures for the June half further confirm the positive story from the exploration side.
Read MoreWhen you have more cash on your books than the company is worth, as Clearview Wealth does, then something needs to be done – hence the ’strategic review’ announced on Friday by the company.
Read MoreASX200 up 24 points (0.3%) to 7509. Coal ; CRN (+2.5%) NHC (+2.7%) WHC (+4.9%). Big upgrades this morning to the coal sector by Macquarie.
Read MoreThe Dow Jones index rose by 131 points or 0.4%. The S&P 500 index added 0.3% to a record high. And the Nasdaq index rose by 22 points or 0.1% to a record high.
Read MoreIn the middle of the second and third round of lockdowns across Australia and some of its global markets, Flight Centre has decided that that is a good time to invest in a new business, with potential.
Read MoreUnited Malt Group says its trading in North America and the UK has improved but it will still make a $22 million provision in its full-year result to cover the impact of Covid Delta on consumption, contractors, and customers.
Read MoreThe Australian Bureau of Statistics revealed that Australia’s trade surplus hit a record in July as exports of iron ore, coal and liquefied natural gas all rose strongly. But is that the peak for the near future?
Read MoreIf you had to take commodity markets – iron ore in particular – as a guide, you’d be right in being confused at the conflicting messages being sent of simultaneous boom and bust.
Read MoreEven as they increase regulatory oversight of the tech sector, Chinese authorities still value the role played by private sector companies in digitising the country’s economy, Janus Henderson’s Adam Wolfman explains.
Read MoreABS lending finance data for July showed that borrower refinancing of housing loan commitments between lenders reached an all-time high of $17.2 billion after an adjusted monthly rise of 6.0%.
Read MorePart Six of Six in a video series with Schroders Australia Fund Manager Simon Adler, in which he tells us how Schroders’ Global Recovery Fund has outperformance of the MSCI World index.
Read MoreThe Aussie market has continued its weaker start to September with the ASX 200 falling a second successive session. The benchmark index lost 41pts or 0.55% to 7,485.
Read MoreThe ASX 200 is down 75pts ~1% near lunch on Thursday as it continues a weak start to September. The market is predominantly being weighed down by heavyweight names trading ex-dividend.
Read MoreThe OPEC + group agreed to stick to its existing policy of gradual oil output increases, despite revising its 2022 demand outlook upwards and continuing pressure from the US.
Read MoreASX200 down 85 points (1.1%) to 7442. ANZ (-0.4%); now expects the RBA will announce a delay in its planned reduction of its weekly bond purchases next week.
Read MoreTechnology shares outperformed as traders turned defensive on concerns about a potential slowing in job hiring. Apple (+0.5%) shares hit all-time highs. And shares of Netflix (+2.3%), Amazon (+0.2%) and Google-owner Alphabet (+0.4%) all advanced.
Read More